MENU
+Compare
VCYT
Stock ticker: NASDAQ
AS OF
Nov 28 closing price
Price
$47.34
Change
-$0.37 (-0.78%)
Capitalization
3.77B

VCYT Veracyte Forecast, Technical & Fundamental Analysis

Veracyte Inc is a genomic diagnostics company... Show more

Industry: #Biotechnology
VCYT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for VCYT with price predictions
Nov 28, 2025

Momentum Indicator for VCYT turns positive, indicating new upward trend

VCYT saw its Momentum Indicator move above the 0 level on November 21, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 100 similar instances where the indicator turned positive. In of the 100 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for VCYT just turned positive on November 21, 2025. Looking at past instances where VCYT's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where VCYT advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 163 cases where VCYT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for VCYT moved out of overbought territory on November 28, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 30 similar instances where the indicator moved out of overbought territory. In of the 30 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VCYT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

VCYT broke above its upper Bollinger Band on November 24, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. VCYT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.975) is normal, around the industry mean (12.507). P/E Ratio (124.579) is within average values for comparable stocks, (139.301). VCYT's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.955). VCYT has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.016). P/S Ratio (7.663) is also within normal values, averaging (9.843).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VCYT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock better than average.

View a ticker or compare two or three
VCYT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

VCYT is expected to report earnings to fall 23.69% to 38 cents per share on March 02

Veracyte VCYT Stock Earnings Reports
Q4'25
Est.
$0.39
Q3'25
Beat
by $0.19
Q2'25
Beat
by $0.33
Q1'25
Beat
by $0.29
Q4'24
Beat
by $0.26
The last earnings report on November 04 showed earnings per share of 50 cents, beating the estimate of 31 cents. With 335.63K shares outstanding, the current market capitalization sits at 3.77B.
A.I. Advisor
published General Information

General Information

a company that discovers, develops and commercializes molecular diagnostic solutions

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
6000 Shoreline Court
Phone
+1 650 243-6300
Employees
815
Web
https://www.veracyte.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMERX13.890.06
+0.43%
Invesco Small Cap Equity R
EKSAX6.58N/A
N/A
Allspring Diversified Income Bldr A
FHCIX74.26N/A
N/A
Fidelity Advisor Health Care I
FPUKX26.34N/A
N/A
Fidelity Puritan K
ESCJX17.09N/A
N/A
1290 Essex Small Cap Growth I

VCYT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, VCYT has been closely correlated with NTLA. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if VCYT jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VCYT
1D Price
Change %
VCYT100%
-0.78%
NTLA - VCYT
69%
Closely correlated
+5.52%
VCEL - VCYT
60%
Loosely correlated
-0.30%
AXON - VCYT
58%
Loosely correlated
+1.31%
DNA - VCYT
57%
Loosely correlated
+1.87%
ABCL - VCYT
55%
Loosely correlated
+2.47%
More